LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the launch of the […]
Tag: PE
Jupiter Endovascular Receives FDA Approval for U.S. Pivotal Study of Vertex Pulmonary Embolectomy System Using Endoportal Control
August 29, 2024 08:00 AM Eastern Daylight Time MENLO PARK, Calif.–(BUSINESS WIRE)–Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal Control™ to bring the precision and control of direct surgical access to catheter-based […]
The global inferior vena cava (IVC) filters market is forecasted to grow at a CAGR of 11.24% during the period 2018-2022
NEW YORK, April 3, 2018 /PRNewswire/ — About Inferior Vena Cava (IVC) Filters The IVCF is a type of vascular filter that is inserted into the inferior vena cava to prevent blood clots from moving from the veins in the legs and pelvis […]
Centers Commence Enrollment in KNOCOUT PE Study to Measure the Impact of Shorter, Even Safer EKOS® Therapy Protocols for Pulmonary Embolism
BOTHELL, Wash.–(BUSINESS WIRE)–BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the commencement of the KNOCOUT PE study. The KNOCOUT PE study will measure how hospitals and patients are benefitting from a new standard of care in the […]